Kazuyoshi Sasaoka

Kazuyoshi Sasaoka

Auto-generated profile, based on publicly available information

Kazuyoshi Sasaoka

Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Hokkaido University , Sapporo 060-0818

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in The Veterinary Journal
Verified
Journal Article
Closed access
RLR. Leela-Arporn
R. Leela-Arporn
HOHiroshi Ohta
Hiroshi Ohta
NNN. Nagata
N. Nagata
KSK. Sasaoka
K. Sasaoka
MTMasahiro Tamura
Masahiro Tamura
MTMitsuyoshi Takiguchi
Mitsuyoshi Takiguchi

19 February 2019 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
KNKhoirun Nisa
Khoirun Nisa
Sue Yee LimSue Yee Lim
Sue Yee Lim
MSMasayoshi Shinohara
Masayoshi Shinohara
TOTatsuyuki Osuga
Tatsuyuki Osuga
NYNozomu Yokoyama
Nozomu Yokoyama
MTMitsuyoshi Takiguchi
Mitsuyoshi Takiguchi
Background: Contrast-enhanced ultrasonography (CEUS) can be used to evaluate intestinal perfusion in healthy dogs. It is helpful for diagnosing and monitoring inflammatory bowel disease in humans and could be useful for dogs with chronic intestinal diseases. Objectives: To examine duodenal perfusion in dogs with chronic inflammatory enteropathy (CIE) and intestinal lymphoma. Animals: Client-owned dogs with CIE (n = 26) or intestinal lymphoma (n = 7) and dogs with gastrointestinal signs but histopathologically normal duodenum (controls, n = 14). Methods: In this cross-sectional study, dogs with CIE were classified into remission (n = 16) and symptomatic (n = 10) groups based on clinical scores determined at the time of CEUS. The duodenum was scanned after IV injection of Sonazoid® (0.01 mL/kg). CEUS-derived perfusion parameters, including time-to-peak, peak intensity (PI), area under the curve (AUC), and wash-in and wash-out rates were evaluated. Results: The PI was significantly higher in the symptomatic CIE group (median (range); 105.4 (89.3-128.8) MPV) than in the control group (89.9 (68.5-112.2) MPV). The AUC was significantly higher in the symptomatic CIE group (4847.9 (3824.3-8462.8) MPV.sec) than in the control (3448.9 (1559.5-4736.9) MPV.sec) and remission CIE (3862.3 (2094.5-6899.0) MPV.sec) groups. The PI and clinical score were positively correlated in the CIE group. No significant differences in perfusion parameters were detected between the lymphoma and CIE groups or the lymphoma and control groups. Conclusions and Clinical Importance: The PI and AUC can detect duodenal inflammation and hence are potentially useful for excluding a diagnosis of CIE.

8 May 2019 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
RLRommaneeya Leela-Arporn
Rommaneeya Leela-Arporn
HOHiroshi Ohta
Hiroshi Ohta
MTMasahiro Tamura
Masahiro Tamura
NNNoriyuki Nagata
Noriyuki Nagata
KSKazuyoshi Sasaoka
Kazuyoshi Sasaoka
MTMitsuyoshi Takiguchi
Mitsuyoshi Takiguchi
Background Metabolomic analysis using blood samples has been suggested to be useful for the early detection of cancer. Among metabolites, plasma-free amino acid (PFAA) profiles are potential diagnostic biomarkers for several diseases including cancer. However, the relationship between PFAA concentrations and liver tumors in dogs remains unknown. Objective To determine the characteristics of PFAA profiles of dogs with hepatocellular carcinoma (HCC) and correlated clinical features. Animals Thirty-four client-owned dogs diagnosed with HCC (n = 26) and benign liver diseases (n = 8) and 11 age-matched healthy dogs. Methods Prospective study using heparinized blood samples from fasted dogs. Plasma was deproteinized, and the concentrations of 21 amino acids were measured using an automated high-performance liquid chromatography amino acid analyzer. Results Plasma glutamic acid concentrations were significantly different among groups (P < .0024 after Bonferroni correction). Compared to healthy dogs, dogs with HCC and benign liver diseases had significantly higher concentrations of glutamic acid by post hoc analysis. However, no significant difference in the PFAA profiles of HCC and benign liver diseases were detected. In addition, preoperative and postoperative PFAA profiles of dogs with HCC were not significantly different. Conclusions and Clinical Importance Increased glutamic acid concentrations might play a role in the development or be a consequence of liver tumor formation. However, PFAA profiles of HCC could not be differentiated from those of benign lesions. In addition, glutamic acid concentrations did not change after surgical resection. These results indicate that PFAA profiles may not be useful biomarkers for detecting HCC in dogs.

1 June 2019 in Journal of Veterinary Cardiology
Verified
Journal Article
Closed access
ADA. Dermlim
A. Dermlim
KNK. Nakamura
K. Nakamura
TMT. Morita
T. Morita
TOT. Osuga
T. Osuga
KNK. Nisa
K. Nisa
MTM. Takiguchi
M. Takiguchi

19 December 2017 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
KSK. Sasaoka
K. Sasaoka
KNK. Nakamura
K. Nakamura
TOT. Osuga
T. Osuga
TMT. Morita
T. Morita
NYN. Yokoyama
N. Yokoyama
MTMitsuyoshi Takiguchi
Mitsuyoshi Takiguchi
Background: Transcranial Doppler ultrasound examination (TCD) is a rapid, noninvasive technique used to evaluate cerebral blood flow and is useful for the detection of intracranial hypertension in humans. However, the clinical usefulness of TCD in diagnosing intracranial hypertension has not been demonstrated for intracranial diseases in dogs. Objectives: To determine the association between the TCD variables and intracranial hypertension in dogs with intracranial diseases. Animals: Fifty client-owned dogs with neurologic signs. Methods: Cross-sectional study. All dogs underwent TCD of the basilar artery under isoflurane anesthesia after magnetic resonance imaging (MRI). Dogs were classified into 3 groups based on MRI findings: no structural diseases (group I), structural disease without MRI evidence of intracranial hypertension (group II), and structural disease with MRI evidence of intracranial hypertension (group III). The TCD vascular resistance variables (resistive index [RI], pulsatility index [PI], and the ratio of systolic to diastolic mean velocity [Sm/Dm]) were measured. Results: Fifteen, 22, and 13 dogs were classified into groups I, II, and III, respectively. Dogs in group III had significantly higher Sm/Dm (median, 1.78; range, 1.44–2.58) than those in group I (median, 1.63; range, 1.43–1.75) and group II (median, 1.62; range, 1.27–2.10). No significant differences in RI and PI were identified among groups. Conclusions and Clinical Importance: Our findings suggest that increased Sm/Dm is associated with MRI findings of suspected intracranial hypertension in dogs with intracranial diseases and that TCD could be a useful tool to help to diagnose intracranial hypertension.

1 January 2019 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
PDF file
ADAngkhana Dermlim
Angkhana Dermlim
TOTatsuyuki Osuga
Tatsuyuki Osuga
KNKensuke Nakamura
Kensuke Nakamura
TMTomoya Morita
Tomoya Morita
KNKhoirun Nisa
Khoirun Nisa
MTMitsuyoshi Takiguchi
Mitsuyoshi Takiguchi
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies